Commission launches consultation on responsible nano research

The European Commission has launched a consultation on responsible research in nanosciences and nanotechnologies.

The consultation is part of the Commission's plan to suggest that the EU Member States sign up to a Code of Conduct for this emerging area of science. A broad spectrum of society is addressed by the consultation, from the scientific community and industry to civil society, policy-makers, media and the general public.

"Nanosciences and nanotechnologies have the potential to drive growth and jobs in Europe, and their development and use should not be delayed, unbalanced or left to chance," said EU Science and Research Commissioner Janez Potocnik. "It is important that we pursue this knowledge with full understanding of the possible implications of these new areas of science, and that we do so openly and involving all concerned."

The Commissioner also stressed that the consultation demonstrates the Commission's commitment to 'developing the potential of nanosciences with appropriate safeguards'.

Estimates as to the market potential of nanotechnology products vary, but are all very positive. The Mitsubishi Institute estimated in 2002 that the market would be worth USD 150 billion (around €110 billion) by 2010, while in 2004 the Lux Research group predicted that the market would be worth USD 2.6 trillion (around €1.9 trillion) by 2014.

If this latter estimate is proved to be accurate, it will mean the nanoscience and nanotechnology market overtaking the information and communication technologies (ICT) market, and growing to 10 times the size of the biotechnology market.

However, concerns over safety have put the brakes on some research into the nanosciences and nanotechnologies. The principal concerns cover the ability of nanoparticles to cross natural bio-boundaries, and the prospect of connecting living creatures and human-made materials and systems.

These concerns have led to the development of a new area of research: the responsible management and control of nanosciences. This involves ethics, safety, the environment, individual rights, and the protection of personal data.

The Code of Conduct would encompass basic principles on which to base future developments in nano research, and would invite signatories to take concrete action to ensure that nanotechnologies are developed in a safe manner.

The consultation will close on 21 September.

For further information, please visit:
http://europa.eu/sinapse/directaccess/
science-and-society/public-debates/nano-recommendation/

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...